Articles

That’s in part because most of his $700 million contract is deferred. Still, his stats this season are worth over $50 million to his team.

Micron shares have shed most of their 2024 gains, but memory pricing could improve in the coming months, Citi says.

The dynamics that fueled the meme-stock frenzy have not gone away, according to a new study.

Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, regulator alleges.

Recent inflation spike — and moderation — underscores its importance

Inflation might actually fall too far, Fed governor says.

Constellation has a new nuclear-power deal with Microsoft. Both Constellation and Vistra shares have more than doubled this year on optimism for data-center power deals.

Small-cap stocks just saw their longest winning streak in three and a half years, after the Federal Reserve recalibrated its monetary policy with a big interest-rate cut. 

Yardeni: Odds of a 1990s-like market boom have increased after Fed rate-cut.

Trump Media & Technology Group Corp.’s stock dropped to its lowest level since it went public in March Friday, as a ban on stock sales lifted.

With Medicare prescription-drug benefits on the brink of a shake-up, enrollees who hope to minimize their costs at the pharmacy counter next year need to stay vigilant in the coming months. 

Investors are facing the busiest quarterly rebalancing in about four years on Friday in a shakeup that could impact roughly $250 billion worth of stocks, according to a team of equity analysts at Piper Sandler.